Search

Roundtable Discussion: Marijuana Rescheduling, Cannabidiol (CBD) Product Pathways, and More While interest in cannabis and cannabis-derived products remains high, the near- and long-term future of federal regulation remains hazy. Hear directly from FDA as they discuss regulation and enforcement in...

In a conversational 30-minute forum over Zoom, Saul Ewing attorneys hosted a discussion on emerging industry developments and common issues that cannabis businesses face today. This month's program featured content covering current regulatory landscape and how it impacts your business. Interested in...

FORT LAUDERDALE, (MARCH 7, 2024) – In joining Saul Ewing as a new partner, Zachary Kobrin brings his insight from having served as general counsel for two companies to his work as a transactional and regulatory lawyer with a focus on cannabis, antitrust and other corporate law. He works in the firm...

Please join Saul Ewing LLP and ARIAS U.S. for a half-day educational workshop and networking opportunity. For event inquiries, please contact info@arias-us.org. Panel Discussions Primer on Mass Tort Bankruptcies and Insolvencies The Current Lay of the Land, Including Scottish Re, Arrowood Crossroads...

This month’s Friday Five covers cases relating to an alleged conflict of interest leading to discovery, two courts’ opposite treatments of subjective pain complaints, a decision that claims of fraud and misrepresentation were not preempted by ERISA and a court’s deference to an insurer’s...

Stephanie Denker, Partner at Saul Ewing LLP, will be speaking at a webinar entitled " Legal Update: A Discussion of Significant Insurance and Reinsurance Cases from 2022 and 2023" on February 27, 2024. The ARIAS•U.S. Law Committee will host this webinar which is focused on significant insurance and...